Cambium Biomaterials, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Cambium Biomaterials, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2025).
SEC Form D · Dec 2025
The industry group it chose in its notices: Other Technology.
SEC Form D · Dec 2025
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Cambium Biomaterials, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| James Griffin | Executive officer | Dec 2025 |
| Nic Madren | Executive officer | Dec 2025 |
| Simon Waddington | Executive officer | Dec 2025 |
| Stephan Herrera | Executive officer | Dec 2025 |
| Tim Gardner | Executive officer | Dec 2025 |
| Eliot Pence | Executive officer | Nov 2023 |
| Andrew Guenthner | Executive officer | Sep 2021 |
| Brett Schneider | Director | Dec 2025 |
| Christopher Pederson | Director | Dec 2025 |
| Francisco Gimenez | Director | Dec 2025 |
| Simon Waddington | Director | Dec 2025 |
| Stephan Herrera | Director | Sep 2021 |